Well it’s good to see them making some progress here. But really they’re about 5 years slower than they should have been. Hopefully they’ll now push on and do a Ph 1 trial and get the ball rolling on this.
And I’m still annoyed that they’re locked out of pursuing 2591 for FXS, given that it’s not going anywhere in a hurry with trof. Though I will give them that these conditions probably reside with the same mob at the FDA as Rett so that should help a bit.
I’m not in anymore but hopefully for everyone else here the momentum will be sustained and the price will go somewhere reasonable.
Ann: Validation for NNZ-2591 neurodevelopmental disorder pipeline, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$16.48 |
Change
-0.290(1.73%) |
Mkt cap ! $2.076B | |||
| Open | High | Low | Value | Volume |
| $16.58 | $16.74 | $16.40 | $9.107M | 549.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 864 | $16.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.50 | 1668 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |